ARCHIVES

Phase III Study: Lymphoseek Superior to Vital Blue Dye

This article is from The Cancer Letter archive.

Vol. 34 No. 6 | June 24, 2011

Download PDF Visit The Full Archive

Related Articles

Interview With AACR’s Margaret Foti: “The Meeting Wouldn’t Have Been The Same.”

April 4, 2003

First-Line Bendamustine Doubles PFS In Non-Hodgkin and Mantle Cell Lymphoma

February 22, 2013

Phase IIb Trial of CRLX101 Fails Overall Survival Endpoint

March 29, 2013

RFA Announcement On Carcinogenesis Extrapolation

August 1, 1980

Ruckdeschel To Direct Nevada Cancer Institute

February 6, 2009

NCI Channels More Money To CIS, 17 Offices Funded

March 9, 1990